News Release

May 02, 2012 07:55 AM Eastern Time

Solazyme and Dow Enter into Contingent Global Commercial Offtake Agreement and Concurrently Sign Phase 2 Joint Development Agreement to Accelerate Commercialization of Bio-based Dielectric Insulating Fluids

Opens in new window

Download

Full Size JPEG, 382x149, 14.5 KB
Small JPEG, 300x117, 10.8 KB
Preview JPEG, 144x56, 4.5 KB
Thumbnail JPEG, 120x46, 3.7 KB

Smart Multimedia Gallery

http://www.businesswire.com/multimedia/dow/20120502005845/en/2617479/Solazyme-and-Dow-Enter-into-Contingent-Global-Commercial-Offtake-Agreement-and-Concurrently-Sign-Phase-2-Joint-Development-Agreement-to-Accelerate-Commercialization-of-Bio-based-Dielectric-Insulating-Fluids

View and Share Graphic

Share

Email

All News | News with Multimedia > Press Release: Solazyme and Dow Enter into Contingent Global C...